
FTI · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $9.93B | $9.08B | $7.82B | $6.70B | $6.40B | $6.53B | $6.95B | $12.55B |
| Cost of Revenue | — | $7.36B | $6.54B | $5.79B | — | — | — | — |
| Research & Development | $83.10M | $73.40M | $69.00M | $67.00M | $78.40M | $75.30M | $149.50M | $189.20M |
| Selling, General & Administrative | $705.30M | $667.10M | $675.90M | $616.80M | $644.90M | $724.10M | $795.70M | $1.14B |
| Operating Expenses | $8.61B | $8.13B | $7.32B | $6.50B | $6.37B | $10.04B | $9.31B | $13.47B |
| Operating Income | $1.44B | $1.16B | $658.20M | $375.90M | $183.40M | -$3.24B | -$2.11B | -$532.70M |
| Interest Expense | — | — | $122.20M | $138.70M | $157.30M | $134.10M | $134.90M | $482.30M |
| Other Income / (Expense) | -$57.70M | -$45.90M | -$248.30M | $5.40M | $46.60M | $25.10M | -$181.60M | -$323.90M |
| Income Before Taxes | $1.27B | $940.40M | $206.60M | $68.90M | $198.10M | -$3.50B | -$2.57B | -$1.49B |
| Provision for Income Taxes | $302.90M | $85.10M | $154.70M | $105.40M | $111.10M | $19.40M | $79.00M | $422.70M |
| Net Income | $963.90M | $842.90M | $56.20M | -$107.20M | $13.30M | -$3.29B | -$2.42B | -$1.92B |
| Basic EPS | $2.34 | $1.96 | $0.13 | -$0.24 | $0.03 | -$7.33 | -$5.39 | -$4.20 |
| Diluted EPS | $2.30 | $1.91 | $0.12 | -$0.24 | $0.03 | -$7.33 | -$5.39 | -$4.20 |
| Basic Shares Outstanding | 412.20M | 429.10M | 438.60M | 449.50M | 450.50M | 448.70M | 448.00M | 458.00M |
| Diluted Shares Outstanding | 419.70M | 440.50M | 452.30M | 449.50M | 454.60M | 448.70M | 448.00M | 458.00M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $3.08 | $2.90 | $3.37 | 12 | ↑5 ↓1 |
| Dec 2027 | $3.52 | $3.03 | $4.31 | 13 | ↑4 ↓2 |
| Dec 2028 | $4.01 | $3.31 | $4.44 | 8 | ↑1 ↓0 |
| Dec 2029 | $4.57 | $4.43 | $4.71 | 2 | ↑0 ↓0 |